Exane Derivatives buys $2,050,986 stake in Morgan Stanley (MS)

Morgan Stanley (MS) : Exane Derivatives scooped up 16,585 additional shares in Morgan Stanley during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 72,167 shares of Morgan Stanley which is valued at $2,050,986.Morgan Stanley makes up approximately 0.34% of Exane Derivatives’s portfolio.

Other Hedge Funds, Including , Pggm Investments boosted its stake in MS in the latest quarter, The investment management firm added 28,451 additional shares and now holds a total of 986,220 shares of Morgan Stanley which is valued at $28,620,104. Morgan Stanley makes up approx 0.14% of Pggm Investments’s portfolio.Umb Bank N Amo boosted its stake in MS in the latest quarter, The investment management firm added 135,615 additional shares and now holds a total of 158,535 shares of Morgan Stanley which is valued at $4,600,686. Morgan Stanley makes up approx 0.19% of Umb Bank N Amo’s portfolio.First Dallas Securities boosted its stake in MS in the latest quarter, The investment management firm added 7,000 additional shares and now holds a total of 19,526 shares of Morgan Stanley which is valued at $566,645. Morgan Stanley makes up approx 0.42% of First Dallas Securities’s portfolio.Nordea Investment Management Ab reduced its stake in MS by selling 13,920 shares or 17.58% in the most recent quarter. The Hedge Fund company now holds 65,247 shares of MS which is valued at $1,877,809. Morgan Stanley makes up approx 0.01% of Nordea Investment Management Ab’s portfolio.

Morgan Stanley opened for trading at $29.02 and hit $29.42 on the upside on Monday, eventually ending the session at $29.12, with a gain of 0.38% or 0.11 points. The heightened volatility saw the trading volume jump to 90,18,550 shares. Company has a market cap of $55,672 M.

On the company’s financial health, Morgan Stanley reported $0.75 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.59. The company had revenue of $8909.00 million for the quarter, compared to analysts expectations of $8312.73 million. The company’s revenue was down -8.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on Morgan Stanley. Company shares were Reiterated by RBC Capital Mkts on Jul 21, 2016 to “Outperform”, Firm has raised the Price Target to $ 32 from a previous price target of $27 .Berenberg Initiated Morgan Stanley on Jul 13, 2016 to “Hold”, Price Target of the shares are set at $29.

Morgan Stanley is a financial holding company. Through its subsidiaries and affiliates the Company provides a variety of products and financial services to a group of clients and customers including corporations governments financial institutions and individuals. The Company’s operating segments include Institutional Securities Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides financial advisory and capital-raising services to a group of corporate and other institutional clients. Wealth Management business segment provides financial services to clients through a network of 16076 global representatives in 622 locations. Investment Management business segment consists of Traditional Asset Management Alternative Investments Merchant Banking and Real Estate Investing activities and offers clients an array of equity fixed income alternative investments real estate and merchant banking strategies.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Morgan Stanley - Is it time to Sell?

Top Brokerage Firms are advising their investors on Morgan Stanley. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.